Effect of Preoperative Cold Therapy on Early Postoperative Outcomes in Total Knee Arthroplasty
The Effect of Preoperatively Initiated Cold Application on Postoperative Bleeding, Pain, and Functional Status in Total Knee Arthroplasty
1 other identifier
interventional
208
1 country
1
Brief Summary
This prospective, single-center, randomized controlled trial investigates the effects of preoperative cold therapy on early postoperative outcomes in patients undergoing unilateral primary total knee arthroplasty (TKA). A total of 208 patients were randomized into two groups: one receiving conventional cold therapy preoperatively and postoperatively, and the other receiving only routine postoperative cold therapy. Primary outcomes included postoperative pain (VAS), edema (thigh circumference), hemoglobin levels, drainage volume, opioid usage, Knee Society Scores (KSS), and presence of ecchymosis. The study demonstrated that initiating cold therapy before surgery significantly reduced postoperative drainage and opioid requirement, and delayed early edema progression. These findings suggest that the timing of cold therapy may influence recovery, highlighting a potentially beneficial approach to perioperative care in TKA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 21, 2025
CompletedAugust 21, 2025
August 1, 2025
1.1 years
August 8, 2025
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Visual Analog Scale (VAS) Scores for Pain
Pain intensity was assessed using the Visual Analog Scale (VAS) at rest at four time points: Preoperative, 8 Hours Postoperative, 24 Hours Postoperative, 48 Hours Postoperative Scale Range: 0 (no pain) - 10 (worst imaginable pain) Directionality: Higher scores indicate worse pain
Preoperative, 8 Hours Postoperative, 24 Hours Postoperative, 48 Hours Postoperative
Postoperative Drainage Volume
Total amount of fluid collected in the Hemovac drainage system during the first 24 hours after total knee arthroplasty (TKA). This measure is used as an indicator of postoperative bleeding and local inflammation, comparing the effect of preoperative cold therapy.
First 24 hours after surgery
Total Opioid Consumption in the First 48 Hours
Total opioid usage calculated as oral morphine equivalent in the first 48 hours after TKA. This includes all administered analgesics converted into oral morphine equivalent doses to evaluate pain control efficacy between study groups.
First 48 hours after surgery
Hemoglobin Level Change
Hemoglobin levels were recorded at four time points to evaluate perioperative blood loss: Preoperative, 8 Hours Postoperative, 24 Hours Postoperative, 48 Hours Postoperative
Preoperative, 8 Hours Postoperative, 24 Hours Postoperative, 48 Hours Postoperative
Knee Society Score (KSS)
Functional outcomes were measured using the KSS scale, which includes pain, range of motion, and stability. Scores were compared preoperatively and at 48 hours postoperatively. Each component is scored from 0 to 100, with higher scores indicating better outcomes.
Preoperative and 48 Hours Postoperative
Thigh Circumference Measurement
Thigh circumference was measured 1 cm proximal to the superior patella border with the knee in full extension, to assess postoperative swelling. Measurements were taken preoperatively, 24 hours postoperatively, and 48 hours postoperatively.
Preoperative, 24 Hours Postoperative, 48 Hours Postoperative
Secondary Outcomes (3)
Presence of Ecchymosis
24 Hours Postoperative and 48 Hours Postoperative
Need for Blood Transfusion
From Surgery Until Hospital Discharge(2 to 7 Days Postoperative)
Length of Hospital Stay
Through Hospital Discharge (Estimated 2 to 7 Days Postoperative)
Study Arms (2)
Preoperative and Postoperative Cold Therapy
EXPERIMENTALPatients in this group received conventional cold therapy (gel pack at -17°C) both before and after surgery. Three sessions were applied preoperatively (20 minutes with 40-minute intervals), and postoperative therapy was performed identically to the control group (20 minutes on / 40 minutes off for 24 hours).
Postoperative Cold Therapy Only
ACTIVE COMPARATORPatients in this group received conventional cold therapy (gel pack at -17°C) after surgery only. Cold packs were applied to the knee region for 20 minutes with 40-minute intervals over a 24-hour postoperative period.
Interventions
Cold therapy was applied using a conventional gel cold pack , pre-cooled at -17°C for at least 2 hours. In the intervention group, cold application was performed three times before surgery (20 minutes per session with 40-minute intervals), and continued postoperatively for 24 hours with the same frequency. This protocol aimed to reduce pain, swelling, bleeding, and improve functional outcomes after total knee arthroplasty.
Cold therapy applied only in the postoperative period, for 24 hours, using the same method as the intervention group (20-minute applications with 40-minute breaks.
Eligibility Criteria
You may qualify if:
- Age ≥ 55 years
- Diagnosed with advanced stage primary osteoarthritis of the knee
- Scheduled for unilateral primary total knee arthroplasty
- Provided written informed consent
You may not qualify if:
- Secondary osteoarthritis (e.g., post-traumatic, inflammatory arthritis)
- History of prior surgery on the affected knee
- Known hypersensitivity or intolerance to cold
- Comorbidities contraindicating cold therapy (e.g., diabetes mellitus, cold urticaria, peripheral vascular disease)
- Bleeding diathesis or on anticoagulant therapy
- History of severe hypertension or cardiovascular disease
- Active neurological or psychiatric disorder
- Allergy to medications used in the study protocol
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
Related Publications (4)
Pieri L, Leggieri F, Bartoli D, Ponti M, Caparrini C, Baldini A. Preoperative knee joint hypothermia reduces inflammation and recovery time and increases range of motion after total knee arthroplasty: A randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2025 Dec;33(12):4312-4323. doi: 10.1002/ksa.12756. Epub 2025 Jul 2.
PMID: 40601965BACKGROUNDChareancholvanich K, Keesukpunt W, Pornrattanamaneewong C, Narkbunnam R, Jarusriwanna A. Comparison of three cryotherapy techniques for early post-TKA pain control in terms of efficacy and patient satisfaction: a randomized controlled trial. Arthroplasty. 2025 Jan 8;7(1):5. doi: 10.1186/s42836-024-00287-7.
PMID: 39773549BACKGROUNDThienpont E. Does advanced cryotherapy reduce pain and narcotic consumption after knee arthroplasty? Clin Orthop Relat Res. 2014 Nov;472(11):3417-23. doi: 10.1007/s11999-014-3810-8. Epub 2014 Jul 25.
PMID: 25059851BACKGROUNDHawker G, Wright J, Coyte P, Paul J, Dittus R, Croxford R, Katz B, Bombardier C, Heck D, Freund D. Health-related quality of life after knee replacement. J Bone Joint Surg Am. 1998 Feb;80(2):163-73. doi: 10.2106/00004623-199802000-00003.
PMID: 9486722BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Care providers such as nurses and physiotherapists responsible for postoperative rehabilitation and routine care were blinded to group allocation. Patients and outcome assessors were not blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopedic Surgeon
Study Record Dates
First Submitted
August 8, 2025
First Posted
August 21, 2025
Study Start
June 10, 2024
Primary Completion
July 30, 2025
Study Completion
August 1, 2025
Last Updated
August 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share